The research reports provided by FirstString Research are top-notch. They are well-researched and provide valuable insights. The website is user-friendly and the customer support team is always helpful. I highly recommend their services!
Haven't used FirstString Research yet?
Ask AI
Ask AI about FirstString Research
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
4 Reviews
I recently subscribed to a research service and I am quite satisfied with the quality of information provided. The reports are well-researched and provide valuable insights. The website is user-friendly and the customer support team is responsive. Overall, a great experience!
I recently came across this research company and I must say I am impressed with their services. The reports provided by them are comprehensive and well-structured. They have a wide range of research topics to choose from, which is great. The website is user-friendly and easy to navigate. The best part is that their services are affordable. Definitely worth giving a try!
I have used the research services of FirstString Research and I must say they are impressive. The reports provided by them are concise and provide valuable insights. The website is user-friendly and the customer support team is always prompt in addressing any queries. I highly recommend their services!
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
or with email
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About FirstString Research
FirstString Research, Inc., a clinical stage biotech company, is leading the translation of cell-cell communication and cell-cell contact/adhesion science into a pipeline of drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The Company has an exclusive worldwide license from the Medical University of South Carolina (MUSC) for the connexin-technology platform and intellectual properties of a portfolio of peptides capable of modulating junctional proteins that are critical for inter-cellular communication. A Phase I human clinical trial demonstrated safety and efficacy of a lead peptide generated from the technology platform. The Company is now advancing GranexinTM Gel, a topical formulation of the lead peptide, through three Phase II human clinical trials for scar reduction and treatment of chronic wounds.
- Website
- firststringresearch.com
- Phone
- 8433883276
- [email protected]
- Address
- 300 W Coleman Blvd Ste 203
